Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
America's new vaccine doctrine for children replaces data with dogma
11:55am, Tuesday, 06'th Jan 2026
In just a few weeks, the U.S. went from a “quiet” recalibration of a single vaccine recommendation to a wholesale retreat from the basic architecture of childhood immunization. That shift is being
Tamboran advancing to full control of Falcon Oil & Gas Australia after shareholder approval
07:16am, Tuesday, 06'th Jan 2026
Tamboran Resources Corporation (ASX:TBN, NYSE:TBN, OTC:TBNRL) has moved a step closer to consolidating full ownership of Falcon Oil & Gas Australia Ltd...
Orthocell delivers record December quarter revenue
05:49am, Tuesday, 06'th Jan 2026
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has delivered record quarterly revenue of $3.2 million for the quarter ended December 31, 2025, supported by ongoing...
Moderna reaffirms 2025-26 guidance, eyes multiple vaccine, oncology, and rare disease launches
04:21pm, Monday, 05'th Jan 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) on Monday reiterated its 2025 revenue guidance of $1.6 billion to $2.0 billion and outlined its pipeline milestones for 2026-28, with the company continuing to foc
Moderna reaffirms 2025-26 guidance, eyes multiple vaccine, oncology, and rare disease launches
11:19am, Monday, 05'th Jan 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) on Monday reiterated its 2025 revenue guidance of $1.6 billion to $2 billion and outlined its pipeline milestones for...
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
07:00am, Monday, 05'th Jan 2026
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda
Bank Pictet & Cie Europe AG Has $8.39 Million Position in Moderna, Inc. $MRNA
03:28am, Friday, 02'nd Jan 2026
Bank Pictet and Cie Europe AG cut its stake in shares of Moderna, Inc. (NASDAQ: MRNA) by 55.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 324,6
Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know
06:45pm, Tuesday, 30'th Dec 2025
In the closing of the recent trading day, Moderna (MRNA) stood at $30.41, denoting a -2.38% move from the preceding trading day.
Cwm LLC Purchases 130,200 Shares of Moderna, Inc. $MRNA
04:08am, Monday, 29'th Dec 2025
Cwm LLC grew its position in Moderna, Inc. (NASDAQ: MRNA) by 50.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 390,333 shares of the c
Forget Moderna Stock, This is a Much Better Buy
10:10am, Saturday, 27'th Dec 2025
Moderna stock soared in the early stages of the pandemic, then struggled -- but in recent times, it's been on the rise. This other biotech has proven itself as a long-term winner.
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
06:46pm, Tuesday, 23'rd Dec 2025
The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.
Stocks Pare Losses, Brush Off Rate Cut Concerns
12:21pm, Tuesday, 23'rd Dec 2025
Stocks are recovering from morning losses, with all three major indexes now eyeing four-straight wins
Top large-cap gainers for Dec. 15-19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine funding news, and a major acquisition deal, with Rocket Lab, Affirm, and cru
MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab
11:10am, Friday, 19'th Dec 2025
Moderna secures up to $54.3 million from CEPI to fund a pivotal phase III study of its mRNA-based H5 pandemic flu vaccine candidate, mRNA-1018.
Down 80%, Should You Buy the Dip on Moderna?
04:10am, Friday, 19'th Dec 2025
Moderna's earnings and stock price climbed during early pandemic days -- that's as demand for the company's coronavirus vaccine soared. Since, the company has faced various challenges that have weighe
